Hold ACN: valuation floor supports but momentum and macro headwinds warrant waiting for pullback
Hold ACN: maintain current weight given genuine valuation floor (12.74x forward P/E, 10.6% FCF yield, $1.78B net cash, 3.38% dividend) but do not add at current levels. The conservative analyst wins the timing argument—fresh MACD sell cross with negative histogram, gap-down rejection at $192 first layer of $192/$195/$199.95 triple-resistance, five-year multiple compression from ~22x to ~13x, and hawkish 93%-no-Fed-cut macro all argue against fresh long engagement. Trim into $192-195 strength, anchor stop at 1.5x ATR (~$176) or close below 50 SMA ($161.45) whichever tighter. Prior decision lessons confirm: when quality name trades beneath declining 200 SMA with negative momentum, technical breakdown outweighs balance-sheet comfort. Wait for pre-committed triggers: (a) confirmed close above $199.95 on volume >=1.5x average OR (b) constructive pullback to $161-165 with MACD histogram re-flipping positive.
ACN is an asymmetric setup being gifted to patient capital at 12.74x forward earnings with a 10.6% FCF yield—half its historical multiple—while the business has compounded from ~$50B to $73B in revenue and the bear's three core arguments (technical rejection, stretched DCF, structural decline) are either misread or already in the price.
| Indicator | Value | Signal |
|---|---|---|
| 50 SMA | 161.45 | bullish |
| 200 SMA | 199.95 | bearish |
| 10 EMA | 186.97 | neutral |
| MACD | 7.08 | bearish |
| MACD Signal | 7.60 | bearish |
| MACD Histogram | -0.52 | bearish |
| RSI | 59.07 | neutral |
| ATR | 6.84 | neutral |
| VWMA | 185.36 | bullish |
| Bollinger Upper Band | 195.14 | neutral |
| Bollinger Middle Band | 183.17 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Forward P/E of 12.74x is below every meaningful historical band; FCF yield of 10.6% is in the top decile of S&P 500 names; dividend + buyback combined yield is ~8.4% of market cap; the stock was at $291 when the same model said 'discount'
↩ rebuts: “DCF Says Premium to Fair Value”
EV: +13%+ (to $210+ target) · concedes: A pullback to the $181-$183 zone (Bollinger mid / 08-26 swing low) that holds would be the highest-quality re-entry; The bear's strongest-sounding point is the 39% five-year drawdown, but it is the weakest in substance; If $181.38 breaks on volume, the thesis is wrong and we re-evaluate; Downside below stop is roughly 3%
ACN faces a technically rejected stock at first resistance with a fresh MACD sell cross, structurally compressed multiples reflecting decelerating growth, and an unfavorable risk/reward where the bull's stop is less than 1× ATR.
· concedes: ACN generates real cash: $12.09B TTM FCF, $7.79B net income, $1.78B net cash position; Current P/E of 12.74x is not at 2021 optimism levels; Q3 FY26 revenue growth of +5.6% YoY was decent; RSI at 59 is neutral-bullish, not overbought; The stock is not at 2021 valuation multiples
→ vs conservative: Entry zone of $161-$165 requires 12% pullback that may never come; waiting for confirmation guarantees underperformance
→ vs conservative: Stop at $150 with $11.50 risk vs $35-$50 upside is 3-to-1 risk-reward, not a reason to stay neutral
→ vs conservative: Waiting for confirmed close above $199.95 means missing the easy money when certainty arrives
→ vs conservative: MACD bearish cross is textbook short-term noise; every major uptrend has had such crosses along the way
→ vs conservative: Rejection at 200-day moving average is healthy consolidation, not bearish action
→ vs neutral: Earnings beat history (2-4% beats consistently) is a real identifiable near-term catalyst
→ vs neutral: COMWARE mid-market expansion is concrete capacity build-out with 180 SAP/CRM professionals and measurable KPIs
→ vs neutral: No ACN-specific catalyst claim ignores Zacks' highlighted 'impressive earnings surprise history'
→ vs conservative: P/E compression from 22x to 13x over five years due to temporary factors (growth slowdown, value rotation) - neither permanent
| Bollinger Lower Band | 171.21 | neutral |
Support: 186.97 · 183.17 · 181.38 · 171.21 | Resistance: 192.06 · 195.14 · 199.95
ACN shows a mixed technical picture: short-term caution due to a fresh MACD bearish cross and rejection candle at $192–193, medium-term bullish structure with price +16% above the 50 SMA and a series of higher swing lows, and long-term unconfirmed with price still below the 200 SMA at $199.95. RSI at 59.07 remains in neutral-bullish territory with room to run, while ATR of $6.84 suggests moderate volatility suitable for ~1.5× ATR stop placement. The analyst recommends HOLD for existing holders with trailing stops at the 10 EMA ($186.97), and suggests new buyers wait for either a pullback holding $181–183 with a positive MACD histogram, or a confirmed daily close above $199.95.
Market Cap
$114.26B
P/E (TTM)
14.93x
Forward P/E
12.74x
PEG Ratio
1.40
Price / Book
3.58x
EPS (TTM)
$12.51
Forward EPS
$14.66
Dividend Yield
3.38%
Beta
1.09
52-Week High
$291.09
52-Week Low
$118.15
Book Value / Share
$52.12
Revenue (TTM)
$73.10B
Gross Margin
32.0%
Operating Margin
16.96%
Net Margin
10.66%
ROE
24.4%
ROA
10.9%
Net Income (TTM)
$7.79B
Total Assets
$68.81B
Total Equity
$33.51B
Total Debt
$8.39B
Cash & Equivalents
$10.17B
Net Cash
$1.78B
Goodwill
$25.32B
Current Ratio
1.34
Operating Cash Flow (TTM)
$13.18B
Free Cash Flow (TTM)
$12.09B
FCF Yield
10.6%
TTM Dividends Paid
$3.93B
TTM Buybacks (gross)
$5.67B
Revenue Growth YoY (Q3 FY26)
+5.6%
Diluted Share Count (YoY change)
(2.3%)
Quarterly Dividend
$1.65/share annualized
Q3 FY26 Revenue
$18.72B
Q3 FY26 Diluted EPS
$3.80
Q3 FY26 Operating Income
$3.18B
Q3 FY26 Gross Margin
32.8%
Working Capital
$7.33B
Deferred Revenue
$6.53B
Strengths
Concerns
Accenture is a high-quality, asset-light professional services firm generating $73.1B in TTM revenue with 16.96% operating margin and 24.4% ROE, trading at a depressed 12.74x forward P/E with 10.6% FCF yield near its 52-week low. The company maintains a net-cash balance sheet ($1.78B) while aggressively returning capital through dividends ($3.93B) and buybacks ($5.67B), though goodwill comprises 37% of assets following $3.6B in M&A over the trailing five quarters. Despite mid-single-digit revenue growth and strong FCF conversion (~155% of net income), the stock faces headwinds from GenAI displacement concerns, FX exposure, and a sustained technical downtrend, supporting a HOLD-to-BUY-accumulate stance for patient investors.
Macro: No Fed cuts in 2026 (93% probability per Polymarket, $8.1M volume); US recession 6% (down 1pp); UK recession 7%; Japan recession 8% (down 13pp); gold/silver lower on blowout jobs report; European energy/inflation resurfacing; hawkish backdrop pressures equity multiples but supports IT consulting budgets.